Human disease glycomics: technology advances enabling protein glycosylation analysis – part 2

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Espert Review of Proteomics

• Publication date

  2018-03-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/14789450.2018.1448710PMID 29521143
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lewis x Antigen is Associated to Head and Neck Squamous Cell Carcinoma Survival

  2018cited by this paper
• Can Biomarkers Help Target Maturity-Onset Diabetes of the Young Genetic Testing in Antibody-Negative Diabetes?

  2018cited by this paper
• The glycosyltransferase GnT-III activates Notch signaling and drives stem cell expansion to promote the growth and invasion of ovarian cancer

  2017cited by this paper
• Tissue glycomics distinguish tumour sites in women with advanced serous adenocarcinoma

  2017cited by this paper
• Biological functions of fucose in mammals.

  2017cited by this paper
• The N-glycosylation of immunoglobulin G as a novel biomarker of Parkinson's disease

  2017cited by this paper
• Selectin Ligands Sialyl-Lewis a and Sialyl-Lewis x in Gastrointestinal Cancers

  2017cited by this paper
• Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer’s disease: an update

  2017cited by this paper
• A unique glycan-isoform of transferrin in cerebrospinal fluid: A potential diagnostic marker for neurological diseases.

  2017cited by this paper
• On the trail of the glycan codes stored in cancer-related cell adhesion proteins.

  2017cited by this paper
• Role of protein glycosylation in cancer metastasis.

  2017cited by this paper
• Perspectives on Anti-Glycan Antibodies Gleaned from Development of a Community Resource Database

  2016cited by this paper
• Epigenetic activation of MGAT3 and corresponding bisecting GlcNAc shortens the survival of cancer patients

  2016cited by this paper
• Changes in glycosylation of human blood plasma chitotriosidase in patients with type 2 diabetes

  2016cited by this paper
• Glycans and glycoproteins as specific biomarkers for cancer

  2016cited by this paper
• Immunoglobulin Glycosylation Effects in Allergy and Immunity

  2016cited by this paper
• Enzymes for N-Glycan Branching and Their Genetic and Nongenetic Regulation in Cancer

  2016cited by this paper
• CSF N-glycoproteomics for early diagnosis in Alzheimer's disease.

  2016cited by this paper
• Enhanced expression of polysialic acid correlates with malignant phenotype in breast cancer cell lines and clinical tissue samples.

  2016cited by this paper
• Site-Specific N-Glycosylation of Recombinant Pentameric and Hexameric Human IgM

  2016cited by this paper
• Sialic acids in cancer biology and immunity.

  2016cited by this paper
• Towards understanding the role of sialylation in melanoma progression.

  2016cited by this paper
• Glial biomarkers in human central nervous system disease

  2016cited by this paper
• The Sweet Side of Immune Evasion: Role of Glycans in the Mechanisms of Cancer Progression

  2016cited by this paper
• The promise of protein glycosylation for personalised medicine.

  2016cited by this paper
• Polysialic acid sustains cancer cell survival and migratory capacity in a hypoxic environment

  2016cited by this paper
• Joining forces: studying multiple post-translational modifications to understand dynamic disease mechanisms

  2016cited by this paper
• Atomic visualization of a flipped-back conformation of bisected glycans bound to specific lectins

  2016cited by this paper
• The Association Between Low Back Pain and Composition of IgG Glycome

  2016cited by this paper
• MassyTools: A High-Throughput Targeted Data Processing Tool for Relative Quantitation and Quality Control Developed for Glycomic and Glycoproteomic MALDI-MS.

  2015cited by this paper
• Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical review.

  2015cited by this paper
• A Microarray-Matrix-assisted Laser Desorption/Ionization-Mass Spectrometry Approach for Site-specific Protein N-glycosylation Analysis, as Demonstrated for Human Serum Immunoglobulin M (IgM)*

  2015cited by this paper
• A single glycan on IgE is indispensable for initiation of anaphylaxis

  2015cited by this paper
• Site-specific O-Glycosylation Analysis of Human Blood Plasma Proteins*

  2015cited by this paper
• Cooperative Interactions of Oligosaccharide and Peptide Moieties of a Glycopeptide Derived from IgE with Galectin-9*

  2015cited by this paper
• Mass spectrometry for glycosylation analysis of biopharmaceuticals

  2015cited by this paper
• Glyco-Predisposing Factor of Diabetes

  2015cited by this paper
• Cancer cell associated glycans as targets for immunotherapy

  2015cited by this paper
• Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics.

  2015cited by this paper
• A common glycan structure on immunoglobulin G for enhancement of effector functions

  2015cited by this paper
• Spatially-resolved exploration of the mouse brain glycome by tissue glyco-capture (TGC) and nano-LC/MS.

  2015cited by this paper
• Inflammatory cytokines regulate the expression of glycosyltransferases involved in the biosynthesis of tumor-associated sialylated glycans in pancreatic cancer cell lines.

  2015cited by this paper
• Terminal Galactosylation and Sialylation Switching on Membrane Glycoproteins upon TNF-Alpha-Induced Insulin Resistance in Adipocytes*

  2015cited by this paper
• Polysialic acid on SynCAM 1 in NG2 cells and on neuropilin‐2 in microglia is confined to intracellular pools that are rapidly depleted upon stimulation

  2015cited by this paper
• Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants

  2015cited by this paper
• Protein glycosylation in cancer.

  2015cited by this paper
• A comprehensive glycome profiling of Huntington's disease transgenic mice.

  2015cited by this paper
• Glycoengineered Monoclonal Antibodies with Homogeneous Glycan (M3, G0, G2, and A2) Using a Chemoenzymatic Approach Have Different Affinities for FcγRIIIa and Variable Antibody-Dependent Cellular Cytotoxicity Activities

  2015cited by this paper
• Glycomic characterization of basal tears and changes with diabetes and diabetic retinopathy.

  2015cited by this paper
• N-Glycomic Changes in Serum Proteins in Type 2 Diabetes Mellitus Correlate with Complications and with Metabolic Syndrome Parameters

  2015cited by this paper
• Paucimannosidic glycoepitopes are functionally involved in proliferation of neural progenitor cells in the subventricular zone.

  2015cited by this paper
• Glycosylation in cancer: mechanisms and clinical implications

  2015cited by this paper
• Pain research funding by the European Union Seventh Framework Programme

  2015cited by this paper
• Decreased O-Linked GlcNAcylation Protects from Cytotoxicity Mediated by Huntingtin Exon1 Protein Fragment*

  2014cited by this paper
• Sialosignaling: sialyltransferases as engines of self-fueling loops in cancer progression.

  2014cited by this paper
• Salivary Protein Glycosylation as a Noninvasive Biomarker for Assessment of Glycemia

  2014cited by this paper
• Expression and glycoengineering of functionally active heteromultimeric IgM in plants

  2014cited by this paper
• Comparative N-glycan profiling of colorectal cancer cell lines reveals unique bisecting GlcNAc and α-2,3-linked sialic acid determinants are associated with membrane proteins of the more metastatic/aggressive cell lines.

  2014cited by this paper
• Genentech's glyco-engineered antibody to succeed Rituxan

  2014cited by this paper
• Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration.

  2014cited by this paper
• Differential Site Accessibility Mechanistically Explains Subcellular-Specific N-Glycosylation Determinants

  2014cited by this paper
• Glycotherapy: new advances inspire a reemergence of glycans in medicine.

  2014cited by this paper
• Cell surface protein glycosylation in cancer

  2014cited by this paper
• Specific Glycosylation of Membrane Proteins in Epithelial Ovarian Cancer Cell Lines: Glycan Structures Reflect Gene Expression and DNA Methylation Status *

  2014cited by this paper
• Enzymatic Sialylation of IgA1 O-Glycans: Implications for Studies of IgA Nephropathy

  2014cited by this paper
• Site-specific N-glycosylation analysis of human immunoglobulin e.

  2014cited by this paper
• Cardiac O-GlcNAcylation blunts autophagic signaling in the diabetic heart.

  2013cited by this paper
• Glycoengineered Pichia-based expression of monoclonal antibodies.

  2013cited by this paper
• Clinical and prognostic implications of β1, 6‐N‐acetylglucosaminyltransferase V in patients with gastric cancer

  2013cited by this paper
• Antibody Glycosylation and Inflammation

  2013cited by this paper
• Changes of the expression of Lewis blood group antigens in glycoproteins of renal cancer tissues.

  2013cited by this paper
• Glycans Are a Novel Biomarker of Chronological and Biological Ages

  2013cited by this paper
• N-Glycosylation modulates the membrane sub-domain distribution and activity of glucose transporter 2 in pancreatic beta cells.

  2013cited by this paper
• Expression of Lewis X is associated with poor prognosis in triple-negative breast cancer.

  2013cited by this paper
• Mutations in HNF1A Result in Marked Alterations of Plasma Glycan Profile

  2013cited by this paper
• Overexpression and β-1,6-N-Acetylglucosaminylation-initiated Aberrant Glycosylation of TIMP-1

  2012cited by this paper
• Fucosylation Is a Promising Target for Cancer Diagnosis and Therapy

  2012cited by this paper
• Regulation of the metastatic cell phenotype by sialylated glycans

  2012cited by this paper
• CSF N-Glycan Profiles to Investigate Biomarkers in Brain Developmental Disorders: Application to Leukodystrophies Related to eIF2B Mutations

  2012cited by this paper
• The bisecting GlcNAc in cell growth control and tumor progression

  2012cited by this paper
• Glycans in Sera of Amyotrophic Lateral Sclerosis Patients and Their Role in Killing Neuronal Cells

  2012cited by this paper
• Regulated expression and neural functions of human natural killer-1 (HNK-1) carbohydrate

  2012cited by this paper
• Glycans as cancer biomarkers.

  2012cited by this paper
• Site-specific glycoproteomics confirms that protein structure dictates formation of N-glycan type, core fucosylation and branching.

  2012cited by this paper
• Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1

  2012cited by this paper
• Expression of glycogenes in differentiating human NT2N neurons. Downregulation of fucosyltransferase 9 leads to decreased Lewis(x) levels and impaired neurite outgrowth.

  2012cited by this paper
• An endoglycosidase with alternative glycan specificity allows broadened glycoprotein remodelling.

  2012cited by this paper
• Chemoenzymatic synthesis and Fcγ receptor binding of homogeneous glycoforms of antibody Fc domain. Presence of a bisecting sugar moiety enhances the affinity of Fc to FcγIIIa receptor.

  2011cited by this paper
• Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport

  2011cited by this paper
• Glycosylation Failure Extends to Glycoproteins in Gestational Diabetes Mellitus

  2011cited by this paper
• Discovering new clinical markers in the field of glycomics.

  2011cited by this paper
• Unique carbohydrate–carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose

  2011cited by this paper
• Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics.

  2011cited by this paper
• Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells

  2011cited by this paper
• Delineating Alzheimer's disease progression with MGAT3, a biomarker for improved prognosis and personalized therapy.

  2011cited by this paper
• MGAT3 mRNA: A Biomarker for Prognosis and Therapy of Alzheimer's Disease by Vitamin D and Curcuminoids

  2011cited by this paper
• High Throughput Isolation and Glycosylation Analysis of IgG–Variability and Heritability of the IgG Glycome in Three Isolated Human Populations

  2011cited by this paper
• Decreased Levels of Bisecting GlcNAc Glycoforms of IgG Are Associated with Human Longevity

  2010cited by this paper
• Tumor and Stem Cell Biology Cancer Research The Bisecting GlcNAc on N-Glycans Inhibits Growth Factor Signaling and Retards Mammary Tumor Progression

  2010cited by this paper
• N-linked glycosylation selectively regulates autonomous precursor BCR function

  2010cited by this paper

• The Use of Glycan Ensemble Structures and Nonpolar Surface Area Distributions for Correlating with Liquid Chromatography Retention Times

  2025cites this paper
• Altered Cell Surface N-Glycosylation Implicates Hypersialylation in Breast Cancer Brain Metastasis.

  2025cites this paper
• An appraisal at a glance of metallome and disease biomarkers.

  2025cites this paper
• TANGO2 binds crystallin alpha B and its loss causes desminopathy

  2025cites this paper
• Reliable N-Glycan Analysis–Removal of Frequently Occurring Oligosaccharide Impurities by Enzymatic Degradation

  2023cites this paper
• Advances in neuroproteomics for neurotrauma: unraveling insights for personalized medicine and future prospects

  2023cites this paper
• Mesoporous materials for glycopeptide separation

  2023cites this paper
• Epigenetic Influences and Brain Development

  2023cites this paper
• Exploring serum glycome patterns after moderate to severe traumatic brain injury: A prospective pilot study

  2022cites this paper
• MS-based glycomics and glycoproteomics methods enabling isomeric characterization.

  2021cites this paper
• Glycosylation Biomarkers Associated with Age-Related Diseases and Current Methods for Glycan Analysis

  2021cites this paper
• The Hitchhiker's guide to glycoproteomics

  2021cites this paper
• Better together – relative retention time plus spectral matching improves automated glycan characterization using PGC-nLC-IT-ESI-MS/MS

  2021cites this paper
• Advances in mass spectrometry‐based glycomics—An update covering the period 2017–2021

  2021cites this paper
• A General New Method for Calculating the Molecular Nonpolar Surface for Analysis of LC-MS Data.

  2020cites this paper
• State-of-the-Art Glycomics Technologies in Glycobiotechnology.

  2020cites this paper
• Separation of Permethylated O-Glycans, Free Oligosaccharides, and Glycosphingolipid-Glycans Using Porous Graphitized Carbon (PGC) Column

  2020cites this paper
• Understanding cellular glycan surfaces in the central nervous system.

  2019cites this paper
• N‐glycome signatures in human plasma: associations with physiology and major diseases

  2019cites this paper
• Revealing the Biological Attributes of N-Glycan Isomers in Breast Cancer Brain Metastasis Using Porous Graphitic Carbon (PGC) Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).

  2019cites this paper
• Systematic Review: Immunoglobulin G N-Glycans as Next-Generation Diagnostic Biomarkers for Common Chronic Diseases.

  2019cites this paper
• Towards a standardized bioinformatics infrastructure for N- and O-glycomics

  2019cites this paper
• Characterization of glycan isomers using magnetic carbon nanoparticles as a MALDI co-matrix

  2019cites this paper
• Boronic acids as building blocks for the construction of therapeutically useful bioconjugates.

  2019cites this paper
• Mass spectrometry analysis of glycoprotein biomarkers in human blood of hepatocellular carcinoma

  2019cites this paper
• Standardization of PGC-LC-MS-based glycomics for sample specific glycotyping.

  2019cites this paper
• Advances in mass spectrometry‐based glycomics

  2018cites this paper
• ON INFORMATICS

  year unknowncites this paper